Stock listing

Tiziana Life Sciences Ltd

Selected listing: TLSA · NASDAQ · USD · US

Tiziana Life Sciences Ltd (NASDAQ:TLSA), Health Technology. Latest release Oct 1, 2026: Telos Corporation Wins New Xacta Contract with U.S. Department…

TLSA:NASDAQUSDUSUpdated September 25, 2026

Ticker: NASDAQ:TLSA
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd (Ticker: TLSA) is a public company based in America, focusing on innovative therapeutic solutions. The company aims to advance its research and development efforts in the life sciences sector.

Latest news from Tiziana Life Sciences Ltd

Telos Corporation Wins New Xacta Contract with U.S. Department of Commerce Office of Inspector General

October 1, 2026

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

September 29, 2026

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

September 29, 2026

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

September 30, 2026

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

September 28, 2026

All Tiziana Life Sciences Ltd news →

Research Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd company profile

View the public company page for Tiziana Life Sciences Ltd on 6ix.

Tiziana Life Sciences Ltd news

Read company news and market updates connected to Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd investor events

Find investor webinars, events, and replay context for Tiziana Life Sciences Ltd.